How Physicians Manage Colchicine-Resistant Familial Mediterranean Fever: Insights From a Multinational Survey in High-Prevalence Countries
Pediatric rheumatologists tended to favor discontinuation of biologic therapy rather than lifelong use. On-demand use of biologics also emerged as a treatment approach among treating physicians. Issues such as colchicine compliance, disease-specific triggers, and the potential to maintain efficacy upon reintroduction of interleukin 1 inhibitors after discontinuation should be prioritized in future research.
Authors
- Y. Bilginer
- Özlem Satirer (ORCID: https://orcid.org/0000-0001-8748-7322)
- M. Gattorno
- Dilara Ünal (ORCID: https://orcid.org/0000-0002-3043-792X)
- Saverio La Bella (ORCID: https://orcid.org/0000-0002-1244-0789)
- Erdal Sag
- Veysel Çam
- Seza Ozen
- Yosef Uziel
- Ozge Basaran
Institutions
- Istituto Giannina Gaslini (IT)
- Meir Medical Center (IL)
- Hacettepe University Hospital (TR)
- University Children's Hospital Tübingen (DE)
- Hacettepe University (TR)
- University of Tübingen (DE)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2026-01-15
- DOI
- https://doi.org/10.3899/jrheum.2025-0804
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00